Psoriasis is an incurable chronic inflammatory disease that requires new interventions. Here, we found that fibroblasts exacerbate psoriasis progression by promoting macrophage recruitment via CCL2 secretion by single-cell multi-omics analysis. The natural small molecule celastrol was screened to interfere with the secretion of CCL2 by fibroblasts and improve the psoriasis-like symptoms in both murine and cynomolgus monkey models. Mechanistically, celastrol directly bound to the low-density lipoprotein receptor-related protein 1 (LRP1) β-chain and abolished its binding to the transcription factor c-Jun in the nucleus, which in turn inhibited CCL2 production by skin fibroblasts, blocked fibroblast-macrophage crosstalk, and ameliorated psoriasis progression. Notably, fibroblast-specific LRP1 knockout mice exhibited a significant reduction in psoriasis like inflammation. Taken together, from clinical samples and combined with various mouse models, we revealed the pathogenesis of psoriasis from the perspective of fibroblast-macrophage crosstalk, and provided a foundation for LRP1 as a novel potential target for psoriasis treatment.

Natural products, and especially the active ingredients found in traditional Chinese medicine (TCM), have a thousand-year-long history of clinical use and a strong theoretical basis in TCM. As such, traditional remedies provide shortcuts for the development of original new drugs in China, and increasing numbers of natural products are showing great therapeutic potential in various diseases. This paper reviews the molecular mechanisms of action of natural products from different sources used in the treatment of inflammatory diseases and cancer, introduces the methods and newly emerging technologies used to identify and validate the targets of natural active ingredients, enumerates the expansive list of TCM used to treat inflammatory diseases and cancer, and summarizes the patterns of action of emerging technologies such as single-cell multiomics, network pharmacology, and artificial intelligence in the pharmacological studies of natural products to provide insights for the development of innovative natural product-based drugs. Our hope is that we can make use of advances in target identification and single-cell multiomics to obtain a deeper understanding of actions of mechanisms of natural products that will allow innovation and revitalization of TCM and its swift industrialization and internationalization.

A global expert consensus (the Delphi consensus) on follicular development, pituitary inhibition, triggering ovulation, and luteal phase support was organized and published in 2021 by Merck Darmstadt, Germany, to further complement the 2019 European Society of Human Reproduction and Embryology (ESHRE) Guidelines on Ovarian Stimulation by in vitro Fertilization (IVF)/Intracytoplasmic Sperm Injection(ICSI). Compared with the ESHRE guidelines, the Delphi consensus incorporates more types of research evidence and expert experience, and finally the expert group has reached a good consensus on follicular development, pituitary suppression and triggering of ovulation, but luteal support is still controversial. This article intends to provide a reference for the optimization of assisted reproductive technology through the interpretation of this consensus.

A global expert consensus (the Delphi consensus) on follicular development, pituitary inhibition, triggering ovulation, and luteal phase support was organized and published in 2021 by Merck Darmstadt, Germany, to further complement the 2019 European Society of Human Reproduction and Embryology (ESHRE) Guidelines on Ovarian Stimulation by in vitro Fertilization (IVF)/Intracytoplasmic Sperm Injection(ICSI). Compared with the ESHRE guidelines, the Delphi consensus incorporates more types of research evidence and expert experience, and finally the expert group has reached a good consensus on follicular development, pituitary suppression and triggering of ovulation, but luteal support is still controversial. This article intends to provide a reference for the optimization of assisted reproductive technology through the interpretation of this consensus.